Organon & Co
OGN7.520USD
-0.190-2.46%
收盤 11/11, 16:00（美東）報價延遲15分鐘
1.96B總市值
3.90本益比TTM
關於 Organon & Co 公司
Organon & Co. 是一家全球醫療保健公司。該公司致力於通過一系列處方療法和女性健康領域的醫療設備、生物仿製藥以及一系列治療領域的成熟藥物特許經營權來開發和提供健康解決方案。該公司擁有一系列避孕和生育品牌，包括 Nexplanon、NuvaRing 和 Follistim AQ。其生物仿製藥產品組合涵蓋免疫學和腫瘤學治療。該公司還擁有一系列成熟品牌，包括心血管、皮膚病學和非阿片類止痛藥領域的品牌。該公司通過各種渠道銷售這些產品，包括藥品批發商和零售商、醫院、政府機構和管理醫療保健提供商，如藥房福利管理機構和其他機構。該公司的產品組合還包括 1% VTAMA（tapinarof）乳膏，這是一種非生物、非甾體外用療法，用於治療成人輕度、中度和重度斑塊狀銀屑病。
Organon & Co簡介
公司代碼OGN
公司名稱Organon & Co
上市日期May 14, 2021
CEOMr. Kevin Ali
員工數量10000
證券類型Ordinary Share
年結日May 14
公司地址30 Hudson Street
城市JERSEY CITY
上市交易所NYSE Consolidated
國家United States of America
郵編07302
電話15514306000
網址https://www.organon.com/
公司代碼OGN
上市日期May 14, 2021
CEOMr. Kevin Ali
Organon & Co公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Matthew M. (Matt) Walsh
Mr. Matthew M. (Matt) Walsh
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
144.48K
+8.57%
Ms. Rachel A. Stahler
Ms. Rachel A. Stahler
Executive Vice President, Chief Digital and Growth Officer
Executive Vice President, Chief Digital and Growth Officer
71.89K
+18.29%
Mr. Aaron Falcione
Mr. Aaron Falcione
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
59.92K
+10.11%
Mr. Kirke Weaver
Mr. Kirke Weaver
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.85K
+17.96%
Mr. Vittorio Nisita
Mr. Vittorio Nisita
Executive Vice President, Head of Enterprise Services & Solutions
Executive Vice President, Head of Enterprise Services & Solutions
41.33K
+26.65%
Ms. Rochelle B. (Shelly) Lazarus
Ms. Rochelle B. (Shelly) Lazarus
Independent Director
Independent Director
633.00
--
Ms. Shalini Sharp
Ms. Shalini Sharp
Independent Director
Independent Director
2.00
--
Ms. Ramona A. Sequeira
Ms. Ramona A. Sequeira
Independent Director
Independent Director
--
--
Mr. Robert A. (Bob) Essner
Mr. Robert A. (Bob) Essner
Lead Independent Director
Lead Independent Director
--
--
Ms. Grace M. Puma Whiteford
Ms. Grace M. Puma Whiteford
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Matthew M. (Matt) Walsh
Mr. Matthew M. (Matt) Walsh
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
144.48K
+8.57%
Ms. Rachel A. Stahler
Ms. Rachel A. Stahler
Executive Vice President, Chief Digital and Growth Officer
Executive Vice President, Chief Digital and Growth Officer
71.89K
+18.29%
Mr. Aaron Falcione
Mr. Aaron Falcione
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
59.92K
+10.11%
Mr. Kirke Weaver
Mr. Kirke Weaver
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.85K
+17.96%
Mr. Vittorio Nisita
Mr. Vittorio Nisita
Executive Vice President, Head of Enterprise Services & Solutions
Executive Vice President, Head of Enterprise Services & Solutions
41.33K
+26.65%
Ms. Rochelle B. (Shelly) Lazarus
Ms. Rochelle B. (Shelly) Lazarus
Independent Director
Independent Director
633.00
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Women’s Health
462.00M
28.98%
Cardiovascular
283.00M
17.75%
Non-Opioid Pain, Bone and Dermatology
250.00M
15.68%
Respiratory
220.00M
13.80%
Other
206.00M
12.92%
Biosimilars
173.00M
10.85%
地區USD
名稱
營收
佔比
Europe and Canada
419.00M
26.29%
United States
414.00M
25.97%
Latin America, Middle East, Russia and Africa
285.00M
17.88%
Asia Pacific and Japan
250.00M
15.68%
China
204.00M
12.80%
Other
22.00M
1.38%
業務
地區
業務USD
名稱
營收
佔比
Women’s Health
462.00M
28.98%
Cardiovascular
283.00M
17.75%
Non-Opioid Pain, Bone and Dermatology
250.00M
15.68%
Respiratory
220.00M
13.80%
Other
206.00M
12.92%
Biosimilars
173.00M
10.85%
股東統計
更新時間: 8月17日 週日
更新時間: 8月17日 週日
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
13.76%
BlackRock Institutional Trust Company, N.A.
10.88%
State Street Investment Management (US)
3.66%
MFS Investment Management
3.63%
Millennium Management LLC
3.50%
其他
64.57%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
13.76%
BlackRock Institutional Trust Company, N.A.
10.88%
State Street Investment Management (US)
3.66%
MFS Investment Management
3.63%
Millennium Management LLC
3.50%
其他
64.57%
股東類型
持股股東
佔比
Investment Advisor
50.05%
Investment Advisor/Hedge Fund
20.42%
Hedge Fund
7.62%
Research Firm
2.69%
Pension Fund
1.84%
Bank and Trust
0.92%
Sovereign Wealth Fund
0.87%
Individual Investor
0.35%
Family Office
0.01%
其他
15.24%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
1485
219.88M
84.58%
-37.41M
2025Q2
1527
205.34M
78.98%
-50.49M
2025Q1
1611
213.21M
82.04%
-52.34M
2024Q4
1647
218.39M
84.67%
-40.43M
2024Q3
1625
211.80M
82.26%
-47.57M
2024Q2
1676
208.67M
81.14%
-51.47M
2024Q1
1700
205.29M
80.30%
-45.21M
2023Q4
1767
202.90M
79.38%
-24.07M
2023Q3
1835
205.61M
80.45%
-25.35M
2023Q2
2016
205.94M
80.75%
-21.55M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
32.15M
12.37%
+2.54M
+8.57%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
28.28M
10.88%
-627.34K
-2.17%
Jun 30, 2025
State Street Investment Management (US)
9.52M
3.66%
+540.48K
+6.02%
Jun 30, 2025
MFS Investment Management
10.11M
3.89%
-469.39K
-4.44%
Jun 30, 2025
Millennium Management LLC
9.09M
3.5%
+8.11M
+829.74%
Jun 30, 2025
LSV Asset Management
7.99M
3.07%
+8.69K
+0.11%
Jun 30, 2025
UBS Financial Services, Inc.
5.93M
2.28%
+4.25M
+253.22%
Jun 30, 2025
Citadel Advisors LLC
5.46M
2.1%
+1.45M
+36.30%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
4.63M
1.78%
+459.24K
+11.02%
Jun 30, 2025
Geode Capital Management, L.L.C.
4.40M
1.69%
-121.50K
-2.69%
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
SPDR S&P Pharmaceuticals ETF
2.5%
Alger Russell Innovation ETF
2.13%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.88%
First Trust Health Care Alphadex Fund
1.87%
Invesco S&P SmallCap Health Care ETF
1.76%
iShares U.S. Pharmaceuticals ETF
1.03%
WisdomTree U.S. SmallCap Dividend Fund
0.79%
Brandes US Small-Mid Cap Value ETF
0.79%
Royce Quant Small-Cap Quality Value ETF
0.78%
Lattice Hartford Multifactor Small Cap ETF
0.73%
查看更多
SPDR S&P Pharmaceuticals ETF
佔比2.5%
Alger Russell Innovation ETF
佔比2.13%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比1.88%
First Trust Health Care Alphadex Fund
佔比1.87%
Invesco S&P SmallCap Health Care ETF
佔比1.76%
iShares U.S. Pharmaceuticals ETF
佔比1.03%
WisdomTree U.S. SmallCap Dividend Fund
佔比0.79%
Brandes US Small-Mid Cap Value ETF
佔比0.79%
Royce Quant Small-Cap Quality Value ETF
佔比0.78%
Lattice Hartford Multifactor Small Cap ETF
佔比0.73%
分紅派息
近5年累計派現
1.03B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Feb 13, 2025
OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Mar 13, 2025 going ex on Feb 24, 2025
Feb 24, 2025
Mar 13, 2025
Feb 24, 2025
Oct 31, 2024
OGN.NB Final Cash Dividend of gross USD 0.28 paid on Dec 12, 2024 going ex on Nov 12, 2024
Nov 12, 2024
Dec 12, 2024
Nov 12, 2024
Aug 06, 2024
OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Sep 12, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Sep 12, 2024
Aug 16, 2024
May 02, 2024
OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Jun 13, 2024 going ex on May 10, 2024
May 13, 2024
Jun 13, 2024
May 10, 2024
Feb 15, 2024
OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Mar 14, 2024 going ex on Feb 23, 2024
Feb 26, 2024
Mar 14, 2024
Feb 23, 2024
Nov 02, 2023
OGN.NB Final Cash Dividend of gross USD 0.28 paid on Dec 14, 2023 going ex on Nov 10, 2023
Nov 13, 2023
Dec 14, 2023
Nov 10, 2023
Aug 08, 2023
OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Sep 14, 2023 going ex on Aug 17, 2023
Aug 18, 2023
Sep 14, 2023
Aug 17, 2023
May 04, 2023
OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Jun 15, 2023 going ex on May 12, 2023
May 15, 2023
Jun 15, 2023
May 12, 2023
Feb 16, 2023
OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Mar 16, 2023 going ex on Feb 24, 2023
Feb 27, 2023
Mar 16, 2023
Feb 24, 2023
Nov 03, 2022
OGN.NB Final Cash Dividend of gross USD 0.28 paid on Dec 15, 2022 going ex on Nov 10, 2022
Nov 14, 2022
Dec 15, 2022
Nov 10, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
